Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.
- 25 October 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (22) , 10703-10706
- https://doi.org/10.1073/pnas.91.22.10703
Abstract
The low-affinity nerve growth factor receptor (NGFR) p75NGFR induces apoptosis in the absence of nerve growth factor (NGF) binding but enhances neural survival when bound by NGF. Basal forebrain cholinergic neurons express the highest levels of p75NGFR in the adult human brain and are preferentially involved in Alzheimer disease, raising the question of whether there may be a functional relationship between the expression of p75NGFR and basal forebrain cholinergic neuronal degeneration in Alzheimer disease. The expression of p75NGFR by wild-type and mutant PC12 cells potentiated cell death induced by beta-amyloid peptide. NGF binding to p75NGFR inhibited the toxicity of beta-amyloid peptide, whereas NGF binding to TrkA, the high-affinity NGFR, enhanced it. These results suggest a possible link between beta-amyloid peptide toxicity and preferential degeneration of cells expressing p75NGFR.Keywords
This publication has 24 references indexed in Scilit:
- Vitamin E protects nerve cells from amyloid βprotein toxicityBiochemical and Biophysical Research Communications, 1992
- Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene productCell, 1992
- Nerve growth factor receptor immunoreactivity in the new world monkey (Cebus apella) and human cerebellumJournal of Comparative Neurology, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's diseaseNeuroscience Letters, 1989
- Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's diseaseActa Neuropathologica, 1988
- THE ROLE OF THE NUCLEUS BASALIS OF MEYNERT IN DEMENTIA: REVIEW AND RECONSIDERATIONAlzheimer Disease & Associated Disorders, 1987
- Neurochemical Studies of Early-Onset Alzheimer's DiseaseNew England Journal of Medicine, 1985
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976